Your browser doesn't support javascript.
loading
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma.
Santini, Daniele; Santoni, Matteo; Conti, Alessandro; Procopio, Giuseppe; Verzoni, Elena; Galli, Luca; di Lorenzo, Giuseppe; De Giorgi, Ugo; De Lisi, Delia; Nicodemo, Maurizio; Maruzzo, Marco; Massari, Francesco; Buti, Sebastiano; Altobelli, Emanuela; Biasco, Elisa; Ricotta, Riccardo; Porta, Camillo; Vincenzi, Bruno; Papalia, Rocco; Marchetti, Paolo; Burattini, Luciano; Berardi, Rossana; Muto, Giovanni; Montironi, Rodolfo; Cascinu, Stefano; Tonini, Giuseppe.
Afiliação
  • Santini D; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Santoni M; Clinica di Oncologia Medica, Università Politecnica delle Marche, AOU Ospedali Riuniti, Ancona, Italy.
  • Conti A; Dipartimento di Scienze Cliniche Specialistiche ed Odontostomatologiche, Clinica di Urologia, AOU Ospedali Riuniti, Ancona, Italy.
  • Procopio G; Oncology Unit I, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
  • Verzoni E; Oncology Unit I, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
  • Galli L; Division of Medical Oncology II, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy.
  • di Lorenzo G; Department of Clinical Medicine, Medical Oncology Unit, Federico II University, Naples, Italy.
  • De Giorgi U; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) - IRCCS, Meldola, Italy.
  • De Lisi D; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Nicodemo M; Sacro Cuore - Don Calabria Hospital, Negrar, Italy.
  • Maruzzo M; Medical Oncology I, Istituto Oncologico Veneto IOV, IRCCS, Padova, Italy.
  • Massari F; Medical Oncology, Azienda Ospedaliera Universitaria Integrata, University of Verona, Verona, Italy.
  • Buti S; Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Altobelli E; Department of Urology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Biasco E; Division of Medical Oncology II, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy.
  • Ricotta R; Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan, Italy.
  • Porta C; IRCCS San Matteo University Hospital Foundation, Pavia, Italy.
  • Vincenzi B; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Papalia R; Department of Urology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Marchetti P; Medical Oncology Unit Policlinico Sant'Andrea, Rome, Italy.
  • Burattini L; Clinica di Oncologia Medica, Università Politecnica delle Marche, AOU Ospedali Riuniti, Ancona, Italy.
  • Berardi R; Clinica di Oncologia Medica, Università Politecnica delle Marche, AOU Ospedali Riuniti, Ancona, Italy.
  • Muto G; Department of Urology, Campus Bio-Medico University of Rome, Rome, Italy.
  • Montironi R; Section of Pathological Anatomy, Polytechnic University of the Marche Region, School of Medicine, AOU Ospedali Riuniti, Ancona, Italy.
  • Cascinu S; Clinica di Oncologia Medica, Università Politecnica delle Marche, AOU Ospedali Riuniti, Ancona, Italy.
  • Tonini G; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy.
Oncotarget ; 7(22): 33381-90, 2016 May 31.
Article em En | MEDLINE | ID: mdl-27027342
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Neoplasias Renais / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Neoplasias Renais / Recidiva Local de Neoplasia / Antineoplásicos Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies Limite: Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article